SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-187996
Filing Date
2021-06-11
Accepted
2021-06-10 18:33:30
Documents
9
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 6-K d188660d6k.htm 6-K 10333
2 EX-99.1 d188660dex991.htm EX-99.1 11895
3 EX-99.2 d188660dex992.htm EX-99.2 270555
4 EX-99.3 d188660dex993.htm EX-99.3 29336
5 GRAPHIC g188660dsp1.jpg GRAPHIC 5215
6 GRAPHIC g188660dsp2.jpg GRAPHIC 2169
7 GRAPHIC g188660dsp40b.jpg GRAPHIC 850
8 GRAPHIC g188660g0610034123399.jpg GRAPHIC 5557
9 GRAPHIC g188660g0610070149421.jpg GRAPHIC 2890
  Complete submission text file 0001193125-21-187996.txt   346834
Mailing Address 400 W ERIE ST SUITE 110 CHICAGO IL 60654
Business Address 400 W ERIE ST SUITE 110 CHICAGO IL 60654 (312) 929-0993
Cresco Labs Inc. (Filer) CIK: 0001832928 (see all company filings)

IRS No.: 981505364 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-56241 | Film No.: 211009363
SIC: 2833 Medicinal Chemicals & Botanical Products